Explore funding opportunities dedicated to driving healthcare innovation. Whether you're developing ground-breaking solutions or leading collaborative research projects, our Funding Directory highlights valuable support to help bring your ideas to life.
The list below provides an overview of current funding opportunities and is updated regularly. Please note, this is not an exhaustive directory and only highlights a selection of available calls.
Our funding team has access to a comprehensive global database of funding calls and initiatives. If you're seeking a more extensive and tailored search to find the right opportunities for your innovation, we’re here to help.
If you’re looking for guidance on the types of funding you can access, innovation stages, or how to navigate the wider research landscape, we’ve created a dedicated set of resources to support you. On our Funding Support page, you can download toolkits that explain key terminology, study designs, and provide practical advice to strengthen your proposal. We also maintain an internal library of templates, such as Gantt charts, logic models, and risk registers, commonly required by funders.
Submit an enquiry if you're looking for guidance, bid review and editing, or help finding the perfect opportunity for your project.
Funding for researchers at non-profit research institutions and SMEs in the UK and overseas to undertake early-stage clinical trials to develop therapeutics, advanced therapies, medical technologies, devices and diagnostics for rare diseases.
The Evidence Synthesis Programme (ESP) funds research projects that identify, evaluate and combine data from existing research studies to provide best evidence. This includes research on the effectiveness and cost-effectiveness of treatments, tests and other interventions. ESP is designed to support evidence synthesis that informs decision-making across health, public health and social care in the UK. The focus of the programme is on evidence synthesis that is based on systematic processes to identify and collate relevant evidence that meets pre-specified eligibility criteria and to minimise the influence of bias. This may include systematic reviews, rapid reviews, scoping reviews or production of evidence maps, statistical review as well as decision analytic modelling.
LifeArc is a UK medical research charity that supports the research, translation and commercialisation of innovative treatments and diagnostics that address unmet medical needs, including rare diseases. LifeArc Ventures is designed to bridge the gap between academic innovations and the early stages of commercialisation/venture funding. It provides early-stage investment for innovative therapeutics, medical devices, health-tech and diagnostics, with a focus on Seed and 'Series A' investment rounds, with significant follow-on investment reserved for successful portfolio companies.
Funding aimed at sending headache specialists (as representatives of IHS) to attend regional meetings, or teach at a headache centre, in countries that might need or want increased headache education and motivation and where, without financial support, attendance of an international specialist would not be possible.
Knowledge Transfer Partnerships aim to promote technology transfer in the UK by facilitating the establishment of project-based partnerships between the knowledge base (universities, colleges and research organisations) and companies using graduate skills.
Funding to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test or other medical intervention development. This fund will provide small scale funding to generate critical data needed prior to seeking more substantive funding.
Wellcome's PhD Fellowships for Health Professionals offer outstanding PhD research training in specific UK institutions to health professionals. Fellowships aim to create knowledge, build research capability and train a diverse group of future leaders in clinical academia, within a positive research culture.
The primary aim of the programme is the evaluation of practical interventions. Primary research (mainly evaluative, but also some preparatory research) and secondary research (evidence synthesis) are funded; methods must be appropriate to the question being asked and the feasibility of the research. Funding supports applications focused on intervention development where an intervention already exists and for which there is an evidence base, but it requires adaptation to situations such as a new context (eg a change in setting, target behaviour or client group) or amalgamation of separate, defined interventions so that they complement each other. Where a compelling case is made, work to establish feasibility and to pilot a definitive intervention will also be funded. NIHR is keen to see applications for large-scale evaluation studies with the potential for national reach.
The CRUK Early Detection and Diagnosis Project Awards fund exceptional science that will drive a transformational change in how and when early cancers and pre-cancerous states are detected and diagnosed. The awards will support a broad range of basic, translational and clinical scientific research, incorporating scientists from diverse fields including molecular biologists, clinicians, engineers, physicists, chemists and mathematicians. Early detection and diagnosis (ED&D) research seeks to detect and diagnose consequential precancerous changes and cancer at the earliest possible point at which an intervention might be made, reducing the burden of late-stage disease.
Grants are available to UK registered charities for a range of charitable projects, including end-of-life care, healthcare and patient support, and education.
Merck’s Medical Innovation Programme (MIP) in Human Reproduction supports translating science into fertility treatments. It builds global collaborations among clinicians, researchers, and engineers to advance therapies and technologies in areas like improving endometrial receptivity, oocyte quality, and sperm viability. Projects are guided by key performance indicators and expert support.
HTA research is undertaken where some evidence already exists to show that a technology can be effective and this needs to be compared to the current standard intervention to see which works best or is most cost-effective. 'Technology' in this context means any health or social care intervention used to: promote health and development; prevent, diagnose or treat disease; or improve rehabilitation, quality of life or long-term care. Examples include procedures, safeguarding interventions, social work interventions, therapeutic drugs, devices, talking therapies, diagnostic tests, settings of care and screening programmes. Research can evaluate any intervention used in the treatment, prevention or diagnosis of disease, provided the primary outcome is health-related and has the potential to directly benefit the wider NHS.
The British Heart Foundation is a charitable organisation dedicated to playing a leading part in efforts to prevent and treat heart disease of all kinds.
Programme grants are provided by the Foundation to support long-term projects on a five-year rolling basis. Proposals should be extensive and imaginative, but remain focused to the key objectives of the British Heart Foundation. Proposals successful in gaining funding are subject to an interim review at the half way stage and are able to apply to have their grant renewed.
The National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research (PGfAR) scheme funds collaborative, multidisciplinary programmes of applied research to solve health and social care challenges. The aim is to deliver research findings that will lead to clear and identifiable patient, service user or carer benefits, typically through promotion of health and wellbeing, prevention of ill health, and optimal disease management (including safety and quality). PGfAR is researcher-led and does not specify topics for research. However, the research must be in an area of priority or need for the NHS, public health or the social care sector, with particular emphasis on health and social care areas that cause significant burden, where other research funders may not be focused or where insufficient funding is available.
The British Heart Foundation (BHF) Clinical Senior Research Fellowship (Clinical SRF) supports outstanding clinician scientists who are looking to grow their research group and have recently been awarded or are on a trajectory to a professorship.
Knowledge Transfer Partnerships is a UK-wide programme that helps businesses and organisations to improve their competitiveness and/or productivity through the better use of the knowledge, technology and skills that reside within higher education institutions, research organisations and further education colleges (known as the 'Knowledge Base' partner.)
The PHR programme funds research to generate evidence to inform the delivery of non-NHS interventions that are intended to improve the health of the public and reduce inequalities in health. The primary aim of the programme is the evaluation of practical interventions. NIHR PHR funds both primary research (mainly evaluative, but also some preparatory research) and secondary research (evidence synthesis).
The British Heart Foundation (BHF) Small Meetings and Events Fund supports the arrangement and organisation of small meetings and events in the UK concerned with areas of cardiovascular science.
International award to recognise senior scientists who - in face of adversity - have made outstanding contributions to antiviral drug discovery and/or development and are dedicated to supporting others in their research career.
The National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research (PGfAR) scheme funds collaborative, multidisciplinary programmes of applied research to solve health and social care challenges. The aim is to deliver research findings that will lead to clear and identifiable patient, service user or carer benefits, typically through promotion of health and wellbeing, prevention of ill health, and optimal disease management (including safety and quality). Potential applicants can undertake appropriate preparatory work through an initial Programme Development Grant (PDG) to strengthen their future programme.
The primary aim of the Bone Cancer Research Trust (BCRT) is to improve outcomes for bone cancer patients through research, awareness, information, and support. The Trust is offering funding to UK-based researchers and clinicians for projects focused on Ewing sarcoma, a rare bone cancer with challenging diagnosis and intensive treatment. Projects at any stage of the research pipeline are eligible, provided they are hypothesis-driven, evidence-based, and clearly demonstrate a potential benefit to patients. Applications are expected to involve patient and public input. The trust prioritises high-impact, innovative, and collaborative research that improves survival and quality of life for Ewing sarcoma patients.
The Medical Innovation Programme (MIP) for Human Reproduction is a successor of the Grant for Fertility Innovation (GFI). It aims to translate biomedical science into clinical applications via connecting participants and their research teams with a range of innovative services and experts in order to exploit health gain in human reproduction. In this collaborative network, Merck promotes clinicians, researchers, embryologists and engineers in testing approaches to develop research and technologies into practice. The MIP follows tracking key performance indicators (KPIs) and enhances collaboration and co-creation across geographies and time zones in all phases of development in the following fertility treatment and innovation areas: Therapies to improve endometrial receptivity and implantation potential via intrauterine administration or other innovative methods. Technologies and treatments to improve oocyte quality and quantity for patients with diminished ovarian reserve. Approaches to diagnose, select, and enhance viability and motility of sperm for IVF/ICSI.
Wellcome's Early Career Awards provide funding for early career researchers from any discipline who are ready to develop their research identity. Through innovative projects, the candidate will be expected to deliver shifts in understanding that could improve human life, health and wellbeing. By the end of the award, the researcher will be ready to lead their own independent research programme. The research project carried out should aim to advance understanding in the candidate's particular field of study and/or develop methodologies, conceptual frameworks, tools or techniques that could benefit health-related research.
The Waterloo Foundation’s Child Development programme funds research, dissemination, and practical projects focused on neurodevelopmental disorders. Grants typically range from £5,000 to £80,000. Funding supports UK-based research, sharing findings, and practical support for families in Wales. Applications vary by grant type, with some open year-round and others on fixed cycles.
Apply for funding to support partnerships to carry out novel collaborative activities between a team of researchers, with interdisciplinarity encouraged where appropriate. You must be employed by an eligible research organisation. The grant will allow you to: establish novel high-value collaborative activities or capabilities, add value to high-quality research activities supported by existing funding, or underpin future funding in our remit build capacity in an area of unmet need.
NIHR's i4i FAST (Funding At the Speed of Translation) Awards scheme is aimed at innovators in need of a small amount of funding to answer a single specific question to address an evidence gap in developing an innovation. FAST funding opportunities are usually themed and projects should align with the research specifications detailed in each FAST call.
The CRUK Biology to Prevention Awards support translational research that employs biological and mechanistic understanding of cancer aetiology, genesis and risk in order to lead to precision prevention interventions. The awards cover a continuum of projects, ranging from new and exploratory research ideas, establishing collaborations, pilot studies to generate data for a new idea, developing novel prevention approaches or repurposing existing approaches, ranging from projects with minimal preliminary data but high scientific rationale, through to longer-term projects grounded in strong preliminary data.
Programme to support research projects relating to public health and social care in the UK that identify, evaluate and combine data from existing research studies to provide best evidence.
The British Heart Foundation (BHF) is a charitable organisation dedicated to playing a leading part in efforts to prevent and treat heart disease of all kinds. BHF Clinical Research Training Fellowships offer medically qualified graduates with a foundation in research training in an established academic or research institution in the UK. Fellowships are usually intended to support the completion of a PhD but applications to complete an MD or equivalent are considered.
The primary aim of the Bone Cancer Research Trust (BCRT) is to find ways of improving the outcomes of Bone Cancer through research, awareness, information and support. The Clinical Trials Support Scheme provides additional support to ongoing clinical trials. The trial may be observational or interventional and can be oncology or surgical. The funding can be used to support: Aligned biological studies, Additional arms or research questions (observational or interventional), Toxicology studies.
The BMBR Programme: Researcher-Led opportunity covers the entire remit of NIHR and MRC, and prioritises current rate-limiting methodological challenges for health research. Funding will be provided for projects that improve the methods used by others in biomedical and health research. Methodology research maximises benefits for researchers, patients and the general population. It also ensures health and social care research and policy are built on the best possible evidence.
The British Heart Foundation is a charitable organisation dedicated to playing a leading part in efforts to prevent and treat heart disease of all kinds. Special Project grants are offered for research projects in the UK with a cost of more than £500,000, and can be used for basic science research, population based cohort studies and studies using datasets. Projects should be relevant to the Foundation and funding can be provided for up to five years, after which the funding will be reviewed. Proposal plans should be extensive and imaginative, but also focused.
The purpose of the Malan Syndrome Foundation Research Grant Program is to advance the current understanding of Malan syndrome and identify disease-modifying treatments. Applications must demonstrate direct relevance to at least one of the following high priority research areas: Creating novel disease models that replicate the human phenotype. Increase understanding of mechanisms regulating NFIX gene expression; identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype. Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system as well as in cardiovascular, orthopaedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.
Funding to help businesses innovate and grow through a mutually beneficial partnership between a business, an academic institution and a graduate. The academic institution employs the recently qualified graduate who works at the company, while the graduate brings new skills and knowledge to the business.
The Better Methods, Better Research (BMBR) Programme is a partnership between the National Institute for Health and Care Research (NIHR) and the Medical Research Council (MRC). It seeks to ensure that optimal research methods are used to advance biomedical, health and care research, policy and delivery across the UK. NIHR recently took over the administration of the BMBR Programme from MRC. Other organisations have input into the BMBR Programme to identify methodological needs, and a variety of stakeholders are consulted to support emerging priority areas.
The Develop Guidance for Better Research Methods opportunity invites applications to develop new guidance on biomedical and health and social care research methods.
The International Cardiovascular Research Partnership Awards (ICRPA) is a partnership research funding scheme between the British Heart Foundation (BHF), the German Centre for Cardiovascular Research (DZHK) the Dutch Heart Foundation (DHF), the Lefoulon-Delalande Foundation (LDF), the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBER-CV). Awards will fund high-quality cardiovascular research projects with the potential to create sustainable international collaborations and contribute to the establishment of the PIs as leaders in their respective fields of research. The scheme focuses on supporting mid-career investigators on a trajectory towards becoming future leaders in cardiovascular research, by enabling them to undertake collaborative work with other such investigators from the partner countries. The scope of the scheme covers innovative research that contributes to improved clinical diagnosis, prevention, or treatment of cardiovascular disease. Partnerships that involve a multidisciplinary approach are strongly encouraged.
Grants for collaborative projects, involving teams of three or more investigators, to research the development of therapeutics for people with cystic fibrosis who do not benefit from CFTR-modulators, including those with rare and nonsense mutations.
Funding is available on an ad hoc basis for researchers worldwide conducting clinical trials of therapeutic options for cancer patients, particularly those options lacking commercial incentive for development.
The Harrington Discovery Institute's Brain Health Medicines Scholar Award provides funding and drug development support to researchers whose work aims to treat, prevent or cure Alzheimer's disease and related dementias.
Research and knowledge dissemination grants concerning the psychological and behavioural development of children, particularly with regard to certain neurodevelopmental conditions and the factors that influence them.
The Engineering and Physical Sciences Research Council (EPSRC) provides the New Investigator Award scheme to support individuals who hold an academic lectureship position at UK higher education institutions, research council institutes, UKRI-approved independent research organisations and NHS bodies, who have not previously led an academic research group or been the recipient of a significant grant. The New Investigator Awards provide foundational funds to enable investigators to initiate a research group coupled with sufficient provision from a host institution to ensure a boost to career development and the underpinning support to establish the applicant within their research field.
Knowledge Transfer Partnerships is a UK-wide programme that helps businesses and organisations to improve their competitiveness and/or productivity through the better use of the knowledge, technology and skills that reside within higher education institutions, research organisations and further education colleges (known as the 'Knowledge Base' partner.) This programme is administered by Innovate UK (IUK).
Funding and venture creation support aimed at researchers funded by Cancer Research UK seeking to develop start-up enterprises to commercialise therapeutics, diagnostics and medical devices for cancer.
Grants are available to support NHS Organisations in the UK to speed up the development of novel community based patient access models that are safe, effective and resource efficient.
Proposals from suitably qualified research teams to produce high-impact Technology Assessment Reviews (TARs). These reviews inform NICE decision-making about which drugs, devices, interventional procedures, and diagnostic tests should be adopted in the NHS. This is an opportunity to play an important role in enabling access to essential medicines and ensuring value for money for the NHS.
Funding available to support research in the UK to develop healthcare technologies to improve rehabilitation and quality of life for prople living with spinal cord injury.
Merck’s Medical Innovation Programme (MIP) for Human Reproduction supports translating research into clinical applications by connecting researchers with expert services. Succeeding the Grant for Fertility Innovation, MIP fosters collaboration to develop fertility treatments, focusing on endometrial receptivity, oocyte quality in low ovarian reserve, and improved sperm diagnosis for IVF/ICSI.
The Dent Disease Foundation is a non-profit patient advocacy organisation based in the USA. Its goal is to educate and connect the community in order to find a cure for Dent disease, a rare genetic kidney disorder which affects males almost exclusively. The Dent Disease Foundation Research Grant Programme is designed to support research that will lead to new diagnostics, treatments and ultimately a cure for Dent disease types 1 and 2. It aims to assist new or established investigators who have research projects for which they need support. The Foundation primarily seeks to fund grants which will increase the understanding of Dent disease and improve the clinical management and treatment of Dent.
NIHR i4i Product Development Awards support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in health or social care systems. Awards are researcher-led and aim to de-risk innovations, supporting early product development and real-world evaluation, to make them more attractive for follow-on funding and further commercial investment.
The CRUK Drug Development Project supports the development of new cancer treatments from preclinical development through to early phase patient trials. The scheme provides non-financial assistance in the form of sponsorship and management from a project team at the CRUK Centre for Drug Development (CDD).
The EPSRC offers network grants to build new interdisciplinary research communities across science, technology, and industry. Grants support UK-based collaborations that promote knowledge exchange, mobility, and innovation. Proposals must demonstrate added value, involve diverse expertise, and align with EPSRC’s remit. SME and international collaborations are encouraged.
The HSDR programme funds evaluative research that seeks to produce rigorous and relevant evidence to improve the quality, accessibility and organisation of health and social care services. Research may be primary (qualitative and/or quantitative), secondary and evidence syntheses. Typical projects are mixed-methods studies with a clear focus on the organisation and quality of care.
The CRUK Prevention and Population Projects Awards provide support for high quality, hypothesis-driven research in primary prevention and population research, including prevention interventional studies. The awards are a maximum of £500,000 over three years to fund research with clear objectives that aims to answer key questions and advance understanding of cancer prevention and how cancer affects the population. The thematic focus of the programme covers cancer aetiology, as well as cancer prevention, epidemiology, behavioural research, statistics and methodology, and clinical trials. Support is available for a wide range of scientific research, from epidemiological studies to chemoprevention clinical trials.
Funding to pump prime clinical trial resources in Wales by increasing workforce capacity and infrastructure relevant to the delivery of commercial clinical research.
Funding is available for businesses, research organisations, third sector organisations, local authorities, and health boards in Wales to invest in new cutting-edge research and innovation that will improve people’s lives.
The Researcher-Led Opportunities workstream seeks proposals on topics or research questions identified by researchers within the programme's remit. The aim is to fund research that will lead to improvements in health and care services that will be of greatest benefit to the NHS and to patients, and/or to social care and clients. NIHR is interested in a range of types of research including primary research and evidence synthesis. NIHR is particularly keen to see large scale studies of national importance.
This early-stage investment fund is backed by the Department for Science, Innovation & Technology (DSIT) and other public bodies. Together, these bodies support the most ambitious UK innovators at seed and beyond to: Facilitate sustainable growth, enhance the health and security of society, deliver economic gains from the UK’s publicly funded research.
The National Institute for Health and Care Research (NIHR) Research Programme for Social Care (RPSC) scheme replaces the previous Research for Social Care (RfSC) scheme. RPSC calls fund research that generates evidence that increases the effectiveness of social care, provides value for money, and benefits people who need or use social care and carers. Research is required that generates evidence to improve, expand and strengthen the way social care is provided for users of care services, carers, the social care workforce and the public across the UK. RPSC funds primary, secondary and evidence synthesis research, including qualitative, quantitative and mixed methods designs. Social care research relevant to both adults and children, and both statutory and non-statutory social care provision, is within scope.
The British Heart Foundation offers Discovery Research PhD Studentships to enable talented students to complete a PhD in cardiovascular science in an established research institution in the UK.
Alzheimer's Research UK (ARUK) aims to make life changing breakthroughs in diagnosis, prevention, treatment and cure of Alzheimer's and related dementias. To do so it provides funding to UK scientists for biomedical research, particularly that which has translational potential for patient benefit. This includes basic preclinical as well as clinical research, but not care or service delivery research.
Duchenne UK is a medical research charity that funds research and clinical trials to accelerate the development of therapies and the search for a cure for Duchenne Muscular Dystrophy (DMD) and to help the current generation of patients with DMD. Duchenne UK may also provide project funding, on a discretionary basis, to support translational research to facilitate the translation of promising therapies from the laboratory to the clinic and to help manage and alleviate symptoms to improve quality of life of people with DMD.
ICURe is a four-stage programme supporting research commercialisation through training, market discovery, and funding. ICURe Engage is a six-week part-time introduction helping researchers identify beneficiaries, value propositions, and entrepreneurship opportunities. ICURe Discover is an eight-week online programme (TRL 1–4/CRL 1–3) focusing on market research, customer insight, and lean start-up testing. ICURe Explore is a 12-week full-time phase (TRL 2–6/CRL 2–5) providing salary support and funding for market validation and global customer discovery. ICURe Exploit offers up to 12 weeks of intensive support for spinouts, preparing company formation and business growth, with access to up to £300,000 follow-on funding funding support.
Programme for researchers from academia and industry to work with the CRUK Centre for Drug Development to develop new cancer treatments, from clinical and pre-clinical development through to early phase patient trials.
Funding for researchers in academia and industry to access research and lab facilities at the University of Dundee and Heriott-Watt University to develop medical technologies, devices and processes that will meet an unmet need within NHS Tayside in Scotland.
Fellowship scheme for researchers or innovators who are either looking to establish or transition to independence. Applications can be submitted in any area of research or innovation covered by UKRI.
Cancer Research Horizons, the translational arm of Cancer Research UK, accelerates the development of innovative cancer therapies, diagnostics, and medical devices. By combining in-house drug discovery, development expertise, industry partnerships, and access to top researchers, it bridges the gap between discovery and enterprise to bring treatments to patients faster.
Its Seed Fund supports this mission through four key funding stages, early validation, pre-seed, seed, and follow-on capital, helping advance technologies from concept to commercialisation. Alongside funding, it offers entrepreneurial training, IP and regulatory guidance, commercial support, expert mentorship, and co-investment opportunities to boost start-up success and impact.
Funding is available for businesses, research organisations, third sector organisations, local authorities, and health boards in Wales to invest in new cutting-edge research and innovation that will improve people’s lives.
Wellcome's Career Development Awards provide funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding that could improve human life, health and wellbeing. Funded research must fit within what Wellcome supports in discovery research. The research project carried out should aim to make a key contribution to the candidate's particular field of study by generating significant shifts in understanding and/or developing methodologies, conceptual frameworks, tools or techniques that could benefit health-related research.
Funding for researchers at non-profit research institutions and SMEs in the UK and overseas to undertake early-stage clinical trials to develop therapeutics, advanced therapies, medical technologies, devices and diagnostics for rare diseases with unmet medical need.
Oracle Head & Neck Cancer UK funds early-stage and proof-of-concept research into head and neck cancers, aiming to address medical and treatment gaps in the UK. It supports single or multi-year projects, including PhDs, aligned with its 2022–2027 strategy: reducing inequalities and improving outcomes and quality of life for patients.
The NIHR Efficacy and Mechanism Evaluation (EME) programme invites researcher-led proposals for clinical science-based projects with a view to improving health or patient care within the NHS.
The CRUK Pre-Doctoral Research Bursary scheme provides short-term funding for clinical academics, including nurses, allied health professionals, healthcare scientists and other clinicians in training to undertake research to explore a career in academic medicine and gain experience and skills in cancer research.
The bursary is intended to give a greater understanding of research before deciding whether to undertake a PhD or MD, and will provide time and resources for the applicant to obtain preliminary data before applying for a higher degree.
The Harrington Discovery Institute offers the Brain Health Medicines Scholar Award to support innovative Alzheimer’s and dementia research. The award provides one year of funding (renewable upon milestone achievement), plus expert support in drug development and commercialization. Ideal projects show scientific rigor, novelty, and strong clinical potential across any therapeutic modality.
The primary aim of the programme is the evaluation of practical interventions. Primary research (mainly evaluative, but also some preparatory research) and secondary research (evidence synthesis) are funded; methods must be appropriate to the question being asked and the feasibility of the research. Funding supports applications focused on intervention development where an intervention already exists and for which there is an evidence base, but it requires adaptation to situations such as a new context (eg a change in setting, target behaviour or client group) or amalgamation of separate, defined interventions so that they complement each other. Where a compelling case is made, work to establish feasibility and to pilot a definitive intervention will also be funded. NIHR is keen to see applications for large-scale evaluation studies with the potential for national reach.
The British Heart Foundation (BHF) provides grants to assist with the cost of providing essential infrastructure to support cardiovascular research in any academic institution in the UK. Funding could be used, for example, to help refurbish a building or purchase major items of equipment to support the activities of several cardiovascular researchers which could not ordinarily be requested on Project or Programme Grants.
Provide the opportunity to undertake a PhD, and exciting and impactful research that will underpin a researcher’s development as an independent future leader
The CRUK Prevention and Population Projects Awards provide support for high quality, hypothesis-driven research in primary prevention and population research, including prevention interventional studies. The awards are a maximum of £500,000 over three years to fund research with clear objectives that aims to answer key questions and advance understanding of cancer prevention and how cancer affects the population.
The JLA PSPs facilitate patients, carers and clinicians to work collaboratively to identify research priorities in particular areas of health and care. The aim is to ensure that health research funders are aware of the issues that are important to the people who need to use the research in their daily lives.
The British Heart Foundation (BHF) Clinical Future Leaders Fellowship (Clinical FLF) will provide long-term support to outstanding clinical researchers, as they transition to independence, leading their own research projects and teams.
Innovative, ambitious UK businesses can benefit from the facilities and expertise provided by Catapults and Research & Technology Organisations (RTOs) through Innovate UK Business Growth.
This programme to support topics and research methodologies that increase the effectiveness of NHS and social care services, provide value for money and benefit patients and the public. This includes a wide range of applied health research, such as: Research into how NHS services are provided and used.
Research evaluating how effective and cost-effective different interventions are. Research examining the resources needed for different ways of delivering healthcare. Feasibility research that can support larger grants from other funders. Development and refining of new interventions, scales, or ways to measure outcomes. Projects exploring how to improve patient health and wellbeing through needs assessments, method development, and exploratory studies. Evidence synthesis and systematic reviews.
The British Heart Foundation (BHF) Discovery Research Early Career Fellowship is aimed to fund exceptional early career researchers. This scheme will provide candidates a platform to broaden their research horizons and start developing their own distinct research leadership.
Funding and venture creation support aimed at researchers funded by Cancer Research UK seeking to develop start-up enterprises to commercialise therapeutics, diagnostics and medical devices for cancer.
Wings for Life (WFL) is an international not-for-profit spinal cord research foundation, headquartered in Austria, that seeks to find a cure for spinal cord injury.
Grants are available to support NHS Organisations in the UK to speed up the development of novel community based patient access models that are safe, effective and resource efficient.
The National Institute for Health and Care Research (NIHR) Public Health Research (PHR) programme funds research to generate evidence to inform the delivery of non-NHS interventions intended to improve the health of the public and reduce inequalities in health. The primary aim of the programme is the evaluation of practical interventions. Primary research (mainly evaluative, but also some preparatory research) and secondary research (evidence synthesis) are funded; methods must be appropriate to the question being asked and the feasibility of the research. Funding supports applications focused on intervention development where an intervention already exists and for which there is an evidence base, but it requires adaptation to situations such as a new context (eg a change in setting, target behaviour or client group) or amalgamation of separate, defined interventions so that they complement each other. Where a compelling case is made, work to establish feasibility and to pilot a definitive intervention will also be funded. NIHR is keen to see applications for large-scale evaluation studies with the potential for national reach.
Rising Tide Foundation is an organisation based in Switzerland with a focus on both clinical cancer research and freedom and prosperity. The Foundation operates a cancer research institution (Rising Tide Foundation for Clinical Cancer Research - RTFCCR) that supports innovative, patient-based research to improve outcomes for people affected by cancer. The Foundation is offering funding to academic institutions and other non-profit organisations to undertake clinical research projects relating to cancer. The key focus areas of research are: Improved patient outcomes, including therapy optimisation, prevention and treatment of symptoms and implementation research.
Science of prevention and detection, including analysis of molecular changes in cancer patients, primary prevention strategy trials and non-invasive monitoring technologies.
Sight Research UK (formerly the National Eye Research Centre) is a research charity that funds pioneering research into the causes of eye disease to develop better prevention methods and more effective treatments for children and adults. Sight Research UK offers a range of grants to support research and related activities related to eye disease and blindness research.
Funding for the purchase of specialist equipment required for ophthalmological research to determine the causes and develop prevention methods and treatments for eye disease and blindness.
The Brittle Bone Society (BBS) is a charity founded in Dundee set up to address the needs of people born with Osteogenesis Imperfecta (OI). The charity brings together clinical experts, professional staff and volunteers to support people in the UK and the Republic of Ireland affected by OI. The BBS works to improve the quality of life of people affected by OI through fundraising to provide services and equipment, raising awareness and advancing knowledge about OI and hosting events on OI. The BBS is looking for applications that fit with its research priorities derived from a survey of OI patients. The key areas of research in OI the charity is looking to fund concern pain management and improving the quality of life of OI patients. The types of research applicable to this grant include but are not limited to: Basic laboratory research, Investigating disease mechanisms, Preclinical experimental studies and clinical research, Health services research.
Wellcome's Discovery Awards provide funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing. The research project carried out should aim to generate significant shifts in understanding and/or develop methodologies, conceptual frameworks, tools or techniques that could benefit health-related research. Research must fit within what Wellcome supports in discovery research.
Research can be in any discipline - including science, technology, engineering and mathematics (STEM), experimental medicine, humanities and social science, clinical/allied health sciences, and public health. Research can be in a single discipline or multidisciplinary.
Funding to charities working in the following areas: Children who have hearing impairment, speech delay, language or communication difficulties, or who have complex needs. Medical innovation and new developments relating to these children. Research in all topics relating to these children.
The Healthcare Infection Society (HIS) offers Travel Grants to support trainees and early-career members attending scientific conferences or meetings to present research on preventing and controlling healthcare-associated infections. The grants help cover registration, travel, accommodation, and subsistence costs, promoting knowledge exchange in infection prevention and hospital-acquired infection control.
Funding is available on an ad hoc basis for researchers worldwide conducting clinical trials of therapeutic options for cancer patients, in particular those options lacking commercial incentive for development.
The scheme supports academically-led projects whose goals are to improve prevention, diagnosis, prognosis, or treatment of significant health needs, or that focus on developing research tools that increase the efficiency of developing interventions. Individual projects can start and finish at any point along the Translationalal pathway from early development and design, pre-clinical testing of novel interventions to early-phase clinical studies and trials (phases 1 and 2a). Applicants must provide sufficient proof-of-concept data in support of their approach. Follow-on proposals may be submitted where the applicant can justify the need for continued support. All human diseases and medical interventions are eligible for support, both in the context of UK healthcare and addressing global health issues. This includes small molecules, peptides, antibodies, vaccines, gene therapy, devices, surgical techniques and psychological approaches.
The CRUK Therapeutic Catalyst programme is designed to accelerate the translation of laboratory findings into novel anti-tumoural single-agent therapeutics. The programme supports exploratory drug discovery to validate and de-risk targets and technologies and position them for further drug discovery research, funding or partnering. Funded projects run collaboratively between academic and Cancer Research Horizons drug discovery laboratories (the Therapeutic Innovation team), with funding awarded by Cancer Research UK.
The Anticancer Fund supports patient-centred cancer research with high scientific value, especially projects overlooked by the pharmaceutical industry. Funding is available for all trial phases, focusing on areas like paediatric solid tumours, gynaecological cancers (excluding breast), brain tumours, and hepatobiliary or pancreatic cancers. Applications must show low trial risk and strong survival impact.
NIHR Programme Development Grants (PDGs) support preparation or enhancement of Programme Grants for Applied Research (PGfAR). Stream A funds early development work such as team building, methods development, evidence synthesis, and stakeholder engagement to strengthen future proposals. Stream B supports existing PGfAR projects through added research, dissemination, data analysis, and implementation activities.
The CRUK Early Detection and Diagnosis Primer Awards provide early stage funding to support new, highly novel and innovative research and pilot studies to address questions within the early detection and diagnosis field. The awards aim to encourage scientists at all career stages to engage with research regarding the early detection of cancer and to drive innovation in how and when cancer is detected.
Funding available to support academic researchers to collaborate with the functional genomics screening laboratory (FGSL) on projects using complex human in vitro models for CRISPR screening to better understand model biology and enable target identification.
Funding for researchers at non-profit research institutions and SMEs in the UK and overseas to undertake early-stage clinical trials to develop therapeutics, advanced therapies, medical technologies, devices and diagnostics for rare diseases with unmet medical need. Applicants must engage with LifeArc before applying.
The EME programme funds ambitious studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. The translational research it supports covers a wide range of new and repurposed interventions, such as diagnostic or prognostic tests and decision-making tools, therapeutics or psychological treatments, medical devices, and public health initiatives delivered in the NHS. The programme primarily supports clinical trials and other robustly designed studies that test the efficacy of interventions that have the potential to improve patient care or benefit the public.
The British Heart Foundation (BHF) is a research charity dedicated to playing a leading part in efforts to prevent and treat heart disease of all kinds. It provides grants through its Clinical Study scheme to support clinical trials and observational studies of specific patient groups, taking place in the UK, with a cost of more than £350,000 or lasting more than three years.
The Lennox-Gastaut Syndrome Foundation (LGS Foundation) is a non-profit organisation based in the United States. Its mission is to improve the lives of individuals affected by Lennox-Gastaut Syndrome, a rare form of childhood-onset epilepsy, through research, programmes and education. The LGS Foundation Cure LGS 365 Research Grants provide funding to seed new basic, translational, and clinical Lennox-Gastaut Syndrome research projects. The Foundation's priority areas are sleep, expressive communication, and EEG network evolution to LGS.
The NIHR Time-Sensitive Research scheme (TSR) is a fast-tracked funding stream. It supports research which addresses demonstrably urgent UK health, public health or social care needs across the following NIHR programmes:
Invention for Innovation (i4i), Research for Patient Benefit (RfPB), Research Programme for Social Care (RPSC), Programme Grants for Applied Research (PGfAR) . Applications must fit within the remit, scope and quality of either of the above programmes and must clearly justify both the public urgency of their work and why the standard funding opportunities are not appropriate. Funding will be awarded only in cases of critical time sensitivity in response to urgent UK health, public health or social care challenges.
The British Heart Foundation (BHF) Discovery Research Senior Fellowship supports leaders in cardiovascular research in their progression towards leading larger scale research programme grants and securing professorship funding.
The Medical Research Council (MRC) offers the MRC Centre of Research Excellence (CoRE) opportunity to support challenge-led applications that focus on distinct, disruptive, multidisciplinary or interdisciplinary activity with the potential to prove transformative to biomedical research, health research or both within 14 years. They should be aligned to the MRC mission.
The Biomedical Catalyst is Innovate UK’s flagship grant funding programme supporting UK small and medium-sized enterprises developing innovative health and life sciences technologies. It helps turn early-stage ideas into commercially viable products such as therapeutics, diagnostics, medical devices, and digital health solutions. The programme funds projects across different stages, from feasibility and early research through to clinical development and market readiness. It aims to reduce risk for investors, strengthen evidence of technical and commercial viability, and accelerate time to market. Run in partnership with UK Research and Innovation, it supports business growth, private investment, and improved healthcare outcomes.
Fellowship funding to enable researchers to visit centres for clinical or diagnostic virology in Europe, with the aim of furthering knowledge in clinical or diagnostic virology.
The Foundation's Conference Awards for Ageing Research support allied health professionals, nurses and pharmacists who are actively involved in ageing-related research and wish to disseminate their findings at national or international conferences. The aim is to support early career researchers who do not have access to conference funds through existing grants or fellowships.
This funding opportunity supports developing data and metadata standards for wearable technology to improve mental health research. Recipients will collaborate with manufacturers, researchers, and ethics experts to enable data integration, like DICOM for imaging. Funding depends on NIH budgets; projects may last up to four years with no budget cap.
Fellowship scheme for early career researchers and innovators looking to establish or transition to independence, or to develop their own ambitious plans within a commercial setting. Fellowships are available in any field of study covered by UK Research and Innovation.
Funding for UK-based universities and providers of care services for high-quality social care research that generates evidence to improve, expand and strengthen the way adult social care in the UK is delivered for users of care services, carers and the public.
Funding over a maximum of three years to support high quality, hypothesis-driven research projects aiming to address key questions and advance understanding of cancer prevention and how cancer affects the population.
Funding over a maximum of five years for translational research by UK research teams - including joint projects with teams in the US and Canada - based on developing a biological and mechanistic understanding of cancer aetiology, genesis and risk to develop precision prevention interventions.
Funding is available for UK-based researchers to develop and implement applied health and social care solutions that help people with arthritis live well and improve long-term outcomes.
Grants to support early career researchers in the UK undertaking translational or proof of concept research in any area of gastroenterology (including pancreatology and hepatology).
Internationally available grants aimed at postdoctoral researchers investigating eye movement desensitisation and reprocessing (EMDR) as a method for the treatment of trauma.
Funding available to UK organisations and educational establishments for the funding of capital infrastructure in the fields of science and medicine, health, education and the arts and humanities.
The Sarcoma UK grants programme funds scientific and medical research to investigate the mechanisms of all forms of bone and soft tissue cancers and develop more effective diagnostics and treatments. Its Research Strategy for 2021-2026 aims to ensure everyone affected by sarcoma receives the best treatment, care, information and support available and focuses on researching causes, diagnostics and treatment to improve quality of life, balanced across multiple sarcoma subtypes.
The Medical Research Foundation Antimicrobial Resistance Research funding call provides targeted grants to support innovative projects addressing drug-resistant infections. It typically offers funding for early- to mid-career researchers, covering research costs and sometimes salary support, with an emphasis on high-risk, high-reward ideas, interdisciplinary approaches, and building research capacity in underfunded areas of antimicrobial resistance.
Fellowship awards to support early and mid-career researchers undertaking research on Antimicrobial Resistance, with a focus on human health research themes.
The Research for Patient Benefit (RfPB) programme is launching a commissioned call that expressly invites applications that focus on the health research priorities identified by the Department of Health and Social Care (DHSC) known as areas of research interest (ARIs).
Funding is available for mechanistically informed trials of interventions for anxiety and depression in young people aged 10-18 years carried out in the UK and/or Africa.
The NIHR is seeking studies that evaluate clinically and cost‑effective early intervention programmes for infants under 12 months who have an increased chance of neurodisability. Funded trials should assess multi‑domain child development outcomes, alongside impacts on parent/carer wellbeing and family functioning, using a randomised controlled design with at least 12 months’ follow‑up.
The NIHR is seeking to fund a single randomised controlled trial evaluating the clinical and cost‑effectiveness of pharmacological treatment - with and without continued cognitive behavioural therapy - for adults receiving NHS gambling treatment services who have not responded adequately to CBT alone.
The NIHR is seeking to fund a single large UK trial evaluating the effectiveness and cost‑effectiveness of Palliative Care Needs Rounds - specialist‑led, structured palliative care support - in residential care homes for older people. The study should use a cluster randomised design with an internal pilot and assess outcomes such as residents’ quality of death, staff and family confidence, hospital admission patterns, and economic impacts on the NHS and care homes.
The NIHR is seeking to fund a single large UK trial evaluating the effectiveness and cost‑effectiveness of Palliative Care Needs Rounds - specialist‑led, structured palliative care support - in residential care homes for older people. The study should use a cluster randomised design with an internal pilot and assess outcomes such as residents’ quality of death, staff and family confidence, hospital admission patterns, and economic impacts on the NHS and care homes.
The NIHR is seeking to fund a single modelling study to determine the clinical and cost‑effectiveness of different transabdominal ultrasound surveillance strategies (including no surveillance) for adults with gallbladder polyps. The study should use robust quantitative modelling and health economic analysis, drawing on existing datasets and potentially new prospective or qualitative data, to compare outcomes such as life expectancy, cancer detection, resource use, and acceptability to patients and staff.
Funding available to support early career researchers working in any discipline to prepare them to lead their own independent research programme and thereby benefit human life, health and wellbeing.
Entry Level Scholarships to support predoctoral researchers in undertaking early stage research projects focused on the prevention of cancer of the cervix and lower genital tract.
Fellowships providing support to postdoctoral midwife researchers for research aiming to improve the practice of midwifery and maternity services, including postnatal care. Research that seeks to improve the health of women, girls and babies across any area of women’s reproductive and gynaecological health will be considered.
Funding for hypothesis-driven projects conducted in any country to advance the biological understanding of GBA1 gene-associated Parkinson's disease (GBA1-PD).
Funding over a maximum of 18 months to support the development of protocols, interventions, novel diagnostics and other research activity that supports the integration of mental health into paediatric rheumatology care for families with Juvenile Myositis (JM).
Funding over a maximum of 18 months to support the development of protocols, interventions, novel diagnostics and other research activity that supports the integration of mental health into paediatric rheumatology care for families with Juvenile Myositis (JM).
Grants to provide support for research proposals that evaluate the impact of point-of-care ultrasound on clinical practice or characterise point-of-care ultrasound learning curves.
The funding bid supports research evaluating community-level initiatives that prevent or reduce loneliness in the UK. It seeks to assess the health and health inequality impacts of interventions—including community assets, place-based approaches, social skills programs, and virtual communities—focusing specifically on loneliness rather than social isolation, to inform effective population-level strategies.
NIHR aims to fund research on how best to improve communication around women’s health across the life course, particularly in underserved or marginalised communities. Of particular interest are interventions that are delivered outside of clinical settings and aim to promote health and wellbeing at the population level, especially through community, voluntary sector, educational or digital settings.
The NIHR HTA seeks applications for a trial on alternate day caplacizumab treatment for immune thrombotic thrombocytopenic purpura (iTTP). The study will assess if alternate day treatment is as effective as daily dosing, reducing risks and costs. It follows a two-stage application process: outline proposal and full application.
The Wellcome Career Development Awards fund mid-career researchers to lead ambitious, independent programmes that advance understanding of human health. Awards typically last up to eight years, covering salary and research costs. Applicants must show leadership potential, innovation, and capacity to become internationally recognised research leaders.
Doctoral and postdoctoral fellowships of up to three years are available for research relating to neuronal ceroid lipofuscinosis (NCL) or childhood dementia.
Grants to support researchers at academic research organisations and research institutes in South West England and South Wales undertaking pilot research projects of relevance to Alzheimer's and other forms of dementia.
Grants to encourage new investigators to work on spinal cord injury regeneration and recovery processes, and to encourage researchers to develop new ideas and/or to transfer their efforts from other areas into spinal cord research.
Grants available for UK researchers working in ophthalmology and vision science to undertake small clinical or non-clinical feasibility and pilot studies to generate preliminary data to support larger, follow-on applications for funding.
Funding available to support academic researchers using AstraZeneca's compound library and screening robots to discover potential research starting points for small molecule medicinal drugs.
The Vanguard Initiative has launched an interregional scheme supporting Welsh organisations to collaborate on innovative projects with partners across Europe. The VInnovate Call will provide financial support (grants) to stakeholders (SMEs cooperating with other companies and/or research/technology centres or universities) located in the VInnovate participating regions. The Call will support activities at TRL6, TRL7 and/or TRL8; meaning that VInnovate will support post-prototyping activities.
The overall goal of this topic is to advance the understanding of older cancer patients' care needs, and develop innovative, age-sensitive care approaches and tools to boost overall quality of life.
This topic aims to improve palliative care for cancer patients by developing innovative, personalized, and integrated models. Focus areas include early care, AI and digital tools for communication and care predictions, and addressing workforce challenges. Proposals should test models in real-world settings, collaborate with EU4Health, and join the EU Cancer Mission’s 'Quality of Life' cluster.
This call funds multidisciplinary research to improve quality of life for cancer patients aged 65+, focusing on understanding care needs, developing age-appropriate interventions, and generating evidence for healthcare systems. Projects should deliver scalable, patient-centred solutions, including clinical studies and stakeholder collaboration, to enhance treatment, follow-up care, and overall wellbeing
This funding supports research to develop and validate microbiome-based tools for early cancer prediction and prevention. It finances longitudinal data collection, AI-driven risk modelling, comparison with liquid biopsy tests, validation in independent cohorts, and stakeholder and citizen engagement to advance personalised, minimally invasive early detection aligned with the EU Cancer Mission.
The EU Cancer Mission seeks to develop a digital platform for mental health support targeting AYA cancer patients (ages 15-39). It should integrate with EU-CIP, offer personalized tools, and be multi-device and multilingual. Collaboration with end-users and experts is essential for testing, validation, and aligning with EU Health Data Space guidelines.
Prize for international teams developing novel interventions for anxiety, depression and psychosis that can improve clinical outcomes and accelerate their adoption, policy impact and real-world implementation.
Proposals for new projects, encompassing PhD studentships, project grants and Innovation grants. These can take place in any cancer-related field and are not limited to any specific cancer type.
The BAPRAS Pump Priming Fund offers a single grant each year to support pump priming clinical trial projects in the field of plastic surgery. The aim of the award is to support early feasibility work for a proposed clinical trial in support of a subsequent application for funding from the NIHR or other large funding body.
Grants to support collaborative research by small research groups of histopathology trainees in different NHS, university and research institutions in the UK and Ireland, leading to publication in a peer-reviewed journal.
The purpose of this Notice of Funding Opportunity (NOFO) is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families and populations.
The Medical Research Council (MRC) provides experimental medicine grants to support academically-led experimental medicine projects that address gaps in current understanding of the causes, progression and treatment of human disease through experimental intervention, or challenge, in humans.
This Pathfinder Challenge aims to accelerate the development and uptake of clinically validated interventions that target the root cause of multiple age-related morbidities.
Sigma Theta Tau International Honour Society of Nursing - known as Sigma - is an international representative body for nurses and nursing. Its mission is to advance world health and celebrate nursing excellence in scholarship, leadership and service, and to respond to trends and issues in nursing and healthcare. In collaboration with the Rosemary Berkel Crisp Foundation, Sigma offers a Research Grant is to support nursing research in the critical areas of women's health, oncology and paediatrics.
Funding to conduct rapid baseline data collection, as well as other feasibility work, prior to intervention implementation, for time-limited opportunities such as a natural experiment or similar evaluations of a new public health intervention.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
The National Cancer Institute (NCI) invites applications for investigator-initiated clinical trials aimed at reducing cancer burden through early detection, prevention, healthcare delivery, quality of life, or survivorship. The trials should improve clinical practice or public health. Budgets are flexible, and the maximum project duration is five years.
Funding to support investigator-initiated studies that employ NEPTUNE and/or CureGN resources to advance clinical and translational research in glomerular disease.
Funding to establish challenge-led MRC Centres of Research Excellence (CoRE) to tackle complex and interdisciplinary health challenges and train the next generation of researchers and technologists.
Funding to establish challenge-led MRC Centres of Research Excellence (CoRE) to tackle complex and interdisciplinary health challenges and train the next generation of researchers and technologists.
This funding supports implementation research to prevent, detect and manage chronic non-communicable diseases from early childhood to young adulthood. It finances evidence-based interventions in LMICs and underserved populations, addressing social determinants of health, equitable delivery, capacity building, and policy-relevant solutions to improve lifelong non-communicable disease outcomes.
Provision of a clinical and academic training environment for a doctor or dentist in the early stages of specialty training to prepare an application for a Training Fellowship leading to a PhD (or equivalent) or, if applicable, a postdoctoral fellowship.
The AI Continent Action Plan identifies the health sector, encompassing life sciences, medical devices and healthcare delivery, as one of the key strategic sectors. The action will contribute to making European life sciences and healthcare more impactful and productive by fostering the full integration of advanced AI in the health sector and biomedical research, along the objectives of the AI in Science strategy and Apply AI strategy.
Applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness and quality of digital mental health interventions that may impact mental health outcomes, including suicide behaviours and serious mental illness.
This NOFO encourages research to improve mental health services for individuals with or at risk for mental illness. It invites non-clinical R01-level projects aligned with NIMH strategic priorities, focusing on factors affecting access, quality, scalability, and outcomes. The maximum project period is five years, with triannual submission deadlines.
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities. The overall goal of this NOFO is to identify cancer risks and risk reduction strategies, to identify factors that cause cancer in humans, and to discover and develop mechanisms for cancer prevention and preventive interventions in humans.
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders.
This funding opportunity supports clinical trials of orphan products (phases 1–3) for rare diseases with unmet medical needs. It aims to evaluate safety and/or efficacy to support new indications or labeling changes, ultimately increasing approved treatments and advancing innovative, collaborative approaches in rare disease drug development.
Capital grants for UK-registered private sector life sciences companies for large-scale R&D projects that are primarily capital investments and dependent on the grant to proceed.
The National Library of Medicine (NLM) seeks applications for innovative research in clinical informatics. The overarching goal of this forthcoming programme is to catalyse the development and advancement of novel informatics methodologies that empower clinicians, patients and the broader public to better understand, manage, and improve health and health care delivery.
